|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
UNAUDITED FINANCIAL STATEMENTS |
|
FOR THE YEAR ENDED 31 DECEMBER 2018 |
|
FOR |
|
MILLENDO THERAPEUTICS LTD |
|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
UNAUDITED FINANCIAL STATEMENTS |
|
FOR THE YEAR ENDED 31 DECEMBER 2018 |
|
FOR |
|
MILLENDO THERAPEUTICS LTD |
MILLENDO THERAPEUTICS LTD (REGISTERED NUMBER: 08318101) |
|
|
|
|
|
|
CONTENTS OF THE FINANCIAL STATEMENTS |
for the Year Ended 31 December 2018 |
|
|
|
|
Page |
|
Company information | 1 |
|
Balance sheet | 2 |
|
Notes to the financial statements | 3 |
|
MILLENDO THERAPEUTICS LTD |
|
COMPANY INFORMATION |
for the Year Ended 31 December 2018 |
|
|
|
|
|
|
|
DIRECTORS: |
|
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
ACCOUNTANTS: |
|
First Floor, Templeback |
10 Temple back |
Bristol |
BS1 6FL |
MILLENDO THERAPEUTICS LTD (REGISTERED NUMBER: 08318101) |
|
BALANCE SHEET |
31 December 2018 |
|
31/12/18 | 31/12/17 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 3 |
|
|
|
CREDITORS |
Amounts falling due within one year | 4 | ( |
) | ( |
) |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT
LIABILITIES |
( |
) |
( |
) |
|
CAPITAL AND RESERVES |
Called up share capital | 5 |
|
|
Retained earnings | 6 | ( |
) | ( |
) |
SHAREHOLDERS' FUNDS | ( |
) | ( |
) |
|
|
|
|
|
The directors acknowledge their responsibilities for: |
(a) |
ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and |
(b) |
preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
|
|
|
In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered. |
|
The financial statements were approved by the Board of Directors on
by: |
|
|
|
|
|
|
|
MILLENDO THERAPEUTICS LTD (REGISTERED NUMBER: 08318101) |
|
NOTES TO THE FINANCIAL STATEMENTS |
for the Year Ended 31 December 2018 |
|
1. | STATUTORY INFORMATION |
|
Millendo Therapeutics Ltd is a
|
company's registered number and registered office address can be found on the Company Information page. |
|
The presentation currency of the financial statements is the Pound Sterling (£). |
|
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Related party exemption |
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The |
Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party |
transactions with wholly owned subsidiaries within the group. |
|
Financial instruments |
The entity's financial instruments include basic financial instruments and consist of cash at bank, trade and other |
debtors and trade and other creditors. Trade and other debtors are recognised initially at transaction price less |
attributable transaction costs. Subsequent to initial recognition they are measured at amortised cost using the |
effective interest method, less any impairment losses in the case of trade debtors. Trade and other creditors are |
also recognised initially at transaction price plus attributable transaction costs. Cash and cash equivalents |
comprise of cash at bank. |
|
Measurement of group loans |
Group loans are initially recognised at transaction price and classified as current liabilities if payment is due |
within one year or less. |
|
Going concern |
The shareholder has confirmed that they will continue to give financial support to the company until such time as |
its financial position improves. |
|
3. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31/12/18 | 31/12/17 |
£ | £ |
Prepayments |
|
|
|
4. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31/12/18 | 31/12/17 |
£ | £ |
Trade creditors |
|
|
Amounts owed to group undertakings |
|
|
Accrued expenses |
|
|
|
|
|
The amount owed to the parent company is unsecured, interest free and repayable on demand. |
MILLENDO THERAPEUTICS LTD (REGISTERED NUMBER: 08318101) |
|
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the Year Ended 31 December 2018 |
|
5. | CALLED UP SHARE CAPITAL |
|
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31/12/18 | 31/12/17 |
value: | £ | £ |
|
Ordinary | $1 | 1 | 1 |
|
6. | RESERVES |
Retained |
earnings |
£ |
|
At 1 January 2018 | ( |
) |
Deficit for the year | ( |
) |
At 31 December 2018 | ( |
) |